Invention Grant
- Patent Title: Method of monomerisation of recombinant antibody molecules
-
Application No.: US15566307Application Date: 2016-04-22
-
Publication No.: US10828366B2Publication Date: 2020-11-10
- Inventor: Sam Philip Heywood , Gavin Barry Wild , Razwan Hanif , Christopher John Le Page
- Applicant: UCB BIOPHARMA SPRL
- Applicant Address: BE Brussels
- Assignee: UCB BIOPHARMA SPRL
- Current Assignee: UCB BIOPHARMA SPRL
- Current Assignee Address: BE Brussels
- Agency: Saliwanchik, Lloyd & Eisenschenk
- Priority: com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@492b1df5
- International Application: PCT/EP2016/059051 WO 20160422
- International Announcement: WO2016/170138 WO 20161027
- Main IPC: C07K1/22
- IPC: C07K1/22 ; C07K16/28 ; C07K16/46 ; C07K16/00 ; A61K39/395 ; C07K1/113 ; C07K16/18 ; C07C323/12 ; C07C323/25 ; C07K5/12

Abstract:
The present invention provides method of increasing the percentage of monomer in a composition of recombinantly expressed antibody molecules characterised in that the antibody molecule comprises at least one Fv with specificity for an antigen of interest comprising one VH and one VL wherein said VH and VL are connected directly or indirectly via one or more linkers and are stabilised by a disulfide bond therebetween, said method comprises: a) a conversion step of treating the composition with a denaturant selected from urea and/or Guanidine hydrochloride; b) wherein step a) is performed in the presence of a reducing agent or after treatment with a reducing agent.
Public/Granted literature
- US20180117153A1 METHOD OF MONOMERISATION OF RECOMBINANT ANTIBODY MOLECULES Public/Granted day:2018-05-03
Information query